Reference
- Hahn, A.F. (1998) "Guillain-Barré syndrome", Lancet, 352, 635 — 641.
- Wen, P.Y., Alyea, E.P., Simon, D., Herbst, R.S., Soiffer, R.J. and Antin, J.H. (1997) "Guillain-Barré syndrome following allogeneic bone marrow transplantation", Neurology, 49, 1711–1714.
- Eliashiv, S., Brenner, T., Abramsky, 0., Shahin, R., Agai, E., Naparstek, E., et al. (1991) "Acute inflammatory demyelinating polyneuropathy following bone marrow transplantation", Bone Marrow Transplantation, 8, 315–317.
- Perry, A., Mehta, J., Iveson, T., Treleaven, J. and Powles, R. (1994) "Guillain-Barré syndrome after bone marrow transplantation", Bone Marrow Transplantation, 14, 165–167.
- Mudad, R., Hussein, A. and Peters, W.P. (1995) "Guillain-Barré syndrome following autologous bone marrow transplantation", American Journal of Clinical Oncology, 18, 167 — 169.
- Rodriguez, V., Kuehnle, I., Heslop, H.E., Khan, S. and Krance, R.A. (2002) "Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation", Bone Marrow Transplantation, 29, 515–517.
- Wright, S.J., Robertson, L.F., O'Brien, S., Plunkett, W. and Keating, M.J. (1994) "The role of fludarabine in haematological malignan-cies", Blood Review, 8, 125— 134.
- Warrel, R.P. and Berman, E. (1986) "Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity", Journal of Clinical Oncology, 4, 74 — 79.